Marimed (MRMD) Non Operating Income (2016 - 2026)
Marimed's (MRMD) quarterly Non Operating Income came in at -$1.2 million in Q1 2026, up 28.6% year-on-year from -$965037.1 in Q1 2025, and up 55.73% on a QoQ basis from -$2.8 million in Q4 2025.
Marimed (MRMD) Non Operating Income (2016 - 2026) Analysis & Trends
Marimed (MRMD) has 11 years of Non Operating Income data on file, last reported at -$1.2 million in Q1 2026.
- On a quarterly basis, Non Operating Income rose 28.6% year-over-year to -$1.2 million in Q1 2026; TTM through Mar 2026 was -$7.5 million, a 7.86% decrease from a year earlier, with the FY2025 full-year figure at -$8.0 million, down 16.89% from the prior year.
- Non Operating Income for Q1 2026 stood at -$1.2 million, up from -$2.8 million in the prior quarter.
- Over the last five years, Non Operating Income for MRMD reached as high as $852000.0 in Q1 2022 and fell as low as -$12.0 million in Q4 2023.
- Historically, Non Operating Income has averaged -$2.2 million across 5 years, with a median of -$1.7 million in 2024.
- Across the five-year window, Non Operating Income soared 155.91% in 2022 and sank 3505.09% in 2023, its largest moves.
- Year by year, Non Operating Income stood at -$334000.0 in 2022, then sank by 3505.09% to -$12.0 million in 2023, then soared by 84.65% to -$1.8 million in 2024, then plunged by 51.68% to -$2.8 million in 2025, then surged by 55.73% to -$1.2 million in 2026.
- Per Business Quant data, the three most recent Non Operating Income figures were -$1.2 million in Q1 2026, -$2.8 million in Q4 2025, and -$1.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -216.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 20.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -7.50 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 53.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Marimed | 23.85 Mn | 14.02 Mn | 15.28 Mn | -1.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.24 Mn |
| Dec 31, 2025 | -2.80 Mn |
| Sep 30, 2025 | -1.78 Mn |
| Jun 30, 2025 | -1.72 Mn |
| Mar 31, 2025 | -1.74 Mn |
| Dec 31, 2024 | -1.85 Mn |
| Sep 30, 2024 | -1.68 Mn |
| Jun 30, 2024 | -1.73 Mn |
| Mar 31, 2024 | -1.62 Mn |
| Dec 31, 2023 | -12.04 Mn |
| Sep 30, 2023 | -3.10 Mn |
| Jun 30, 2023 | -2.54 Mn |
| Mar 31, 2023 | -3.31 Mn |
| Dec 31, 2022 | -334,000.00 |
| Sep 30, 2022 | -530,000.00 |
| Jun 30, 2022 | -849,000.00 |
| Mar 31, 2022 | 852,000.00 |
| Dec 31, 2021 | -435,000.00 |
| Sep 30, 2021 | -488,000.00 |
| Jun 30, 2021 | -600,000.00 |